Katherine S.  Zanotti net worth and biography

Katherine Zanotti Biography and Net Worth

Director of Cutera
Katherine S. Zanotti has served as a member of our Board since February 2019. She previously served as chief executive officer of Arbonne International from August 2009 until June 2018. Ms. Zanotti has also served as Chairman of Natural Products Group (the holding company of Arbonne, Natures Gate, and Levlad) since March 2010. From July 2002 to March 2006, she served as senior vice president of marketing at McDonald’s Corporation. Ms. Zanotti is a retired vice president of the Procter & Gamble Company and most recently served as vice president and general manager of the North American pharmaceutical business and the corporate women’s health platform. Ms. Zanotti currently serves on the Board of Exact Sciences, as a member of the Board of Trustees of Xavier University. She previously served as a director of Hill-Rom Holdings, Inc., a worldwide manufacturer and provider of medical technologies and related services; Mentor Corporation, a medical device company; Alberto Culver Company, a personal care products company; and Third Wave Technologies, Inc., a molecular diagnostics company. She earned a bachelor’s degree in economics and studio fine arts from Georgetown University and an MBA in marketing and finance from Xavier University.

What is Katherine S. Zanotti's net worth?

The estimated net worth of Katherine S. Zanotti is at least $30,466.62 as of July 26th, 2022. Ms. Zanotti owns 60,318 shares of Cutera stock worth more than $30,467 as of November 8th. This net worth estimate does not reflect any other assets that Ms. Zanotti may own. Learn More about Katherine S. Zanotti's net worth.

How do I contact Katherine S. Zanotti?

The corporate mailing address for Ms. Zanotti and other Cutera executives is 3240 BAYSHORE BOULEVARD, BRISBANE CA, 94005. Cutera can also be reached via phone at (415) 657-5500 and via email at [email protected]. Learn More on Katherine S. Zanotti's contact information.

Has Katherine S. Zanotti been buying or selling shares of Cutera?

Katherine S. Zanotti has not been actively trading shares of Cutera during the last ninety days. Most recently, on Monday, November 29th, Katherine S. Zanotti bought 1,307 shares of Cutera stock. The stock was acquired at an average cost of $37.63 per share, with a total value of $49,182.41. Learn More on Katherine S. Zanotti's trading history.

Who are Cutera's active insiders?

Cutera's insider roster includes David Mowry (CEO), Timothy Oshea (Director), J. Plants (Director), Rohan Seth (CFO), Joseph Whitters (Director), and Katherine Zanotti (Director). Learn More on Cutera's active insiders.

Are insiders buying or selling shares of Cutera?

During the last year, insiders at the medical device company sold shares 2 times. They sold a total of 35,788 shares worth more than $91,172.20. The most recent insider tranaction occured on May, 16th when EVP Michael Karavitis sold 24,940 shares worth more than $64,594.60. Insiders at Cutera own 0.4% of the company. Learn More about insider trades at Cutera.

Information on this page was last updated on 5/16/2024.

Katherine S. Zanotti Insider Trading History at Cutera

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/29/2021Buy1,307$37.63$49,182.41View SEC Filing Icon  
8/21/2020Buy3,085$16.36$50,470.6020,178View SEC Filing Icon  
See Full Table

Katherine S. Zanotti Buying and Selling Activity at Cutera

This chart shows Katherine S Zanotti's buying and selling at Cutera by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cutera Company Overview

Cutera logo
Cutera, Inc. provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform. It also offers truSculpt, a high-powered radio frequency system designed for circumferential reduction, lipolysis, and deep tissue heating and treat all skin types; Secret RF, a fractional RF microneedling device that delivers heat into the deeper layers of the skin using controlled RF energy; and Enlighten SR/III, a laser platform with a dual wavelength for multi-colored tattoo removal, and the treatment of benign pigmented lesions and acne scars. In addition, the company provides Excel HR, a hair removal solution for all skin types; xeo, a multi-application platform for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity; and Secret DUO, two dual non-ablative fractional technologies that can be used individually or in combination to target a variety of aesthetic concerns and skin conditions on all skin types with little to no downtime. Further, it offers its products through direct sales and services, and network of distributors and direct international sales. Cutera, Inc. was incorporated in 1998 and is headquartered in Brisbane, California.
Read More

Today's Range

Now: $0.39
Low: $0.36
High: $0.51

50 Day Range

MA: $0.70
Low: $0.51
High: $0.82

2 Week Range

Now: $0.39
Low: $0.36
High: $4.97

Volume

2,127,622 shs

Average Volume

914,130 shs

Market Capitalization

$7.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.35